Reciprocal IVF Success Rates by Age of Egg Provider

Reciprocal IVF, where one partner provides the eggs and the other carries the pregnancy, delivers live birth rates in the range of about 46 to 52 percent per embryo transfer. That figure sits squarely alongside conventional IVF outcomes, and multiple studies now confirm the method does not come with a success-rate penalty. The picture gets more interesting when you look at cumulative odds across multiple cycles, the role of each partner’s age, and a handful of pregnancy-related risks specific to carrying someone else’s embryo.

How Per-Transfer Success Compares to Standard IVF

The most straightforward way to judge reciprocal IVF is to compare it cycle for cycle with traditional IVF, where the same person provides the eggs and carries the pregnancy. A study published in the Journal of Assisted Reproduction and Genetics looked at a large group of reciprocal IVF (sometimes called ROPA) cycles alongside standard IVF cycles and found live birth rates of about 46 percent versus 41 percent per embryo transfer. The difference was not statistically meaningful, and it stayed insignificant even after adjusting for age and body mass index of the egg providers and the recipients.¹

A 2025 study in JAMA reached a similar conclusion with slightly higher numbers on both sides. Reciprocal IVF cycles had a clinical pregnancy rate of 64 percent and a live birth rate of 52 percent, compared to 57 percent and 48 percent for autologous IVF cycles. After multivariable adjustment, the difference again disappeared, with adjusted risk ratios hovering right around 1.0.² The short version: if you are deciding between reciprocal IVF and having one partner do both parts, the success rates alone should not push you in either direction.

A systematic review and meta-analysis comparing co-IVF against other pathways, including intrauterine insemination, heterosexual IVF, and own-egg IVF among lesbian couples, actually found that co-IVF had higher clinical pregnancy and live birth rates. That finding likely reflects selection effects, since couples choosing reciprocal IVF may be starting with two fertile partners and picking the one with the better egg supply to provide the oocytes.³

Cumulative Success Across Multiple Cycles

Per-transfer rates tell you the chance of success on any single attempt. But most people going through IVF want to know their odds of eventually having a baby, even if the first transfer does not work. Here the numbers for reciprocal IVF look encouraging, though they vary between studies. A large UK-based study reported a cumulative live birth rate of 60 percent per receiving partner, with a twin delivery rate of about 14 percent among those who gave birth.⁴

Another study found even more striking results when comparing cumulative outcomes between reciprocal IVF and standard IVF in lesbian couples. The cumulative live birth rate after ROPA was about 66 percent versus 43 percent for autologous IVF, a gap that remained significant even after statistical adjustment. The adjusted odds of cumulative live birth were roughly two and a half times higher in the reciprocal group.⁵ That large advantage probably reflects a built-in benefit of having two potential egg providers. Clinicians can steer the egg-retrieval role toward the younger or more ovarian-reserve-rich partner, which boosts embryo quality from the start.

A Brazilian fertility clinic published data showing live birth rates per treatment as high as 79 percent for ROPA, compared with 58 percent for standard IVF and 80 percent for treatments using donated oocytes or embryos from outside the couple.⁶ That 79 percent figure is notably high, and it may reflect a clinic with particularly favorable patient demographics or aggressive cycle management. Still, the overall trend across studies is consistent: cumulative success with reciprocal IVF is at least as good as standard IVF and often better, largely because of the strategic advantage of choosing the best egg source within the couple.

Why the Egg Provider’s Age Is the Biggest Variable

The most reliable predictor of IVF success, reciprocal or otherwise, is the age of the person whose eggs are being used. Egg quality declines with age, and that decline accelerates after the mid-thirties. In reciprocal IVF, the person carrying the pregnancy does not need to have young ovaries; she needs a healthy uterus, and uterine receptivity holds up fairly well into the early forties. What matters is the age of the partner who goes through egg retrieval.

The JAMA study found that both partners in couples pursuing reciprocal IVF tended to be younger than those opting for autologous IVF, and there was a moderate correlation between the ages of the two partners. That makes intuitive sense: younger couples are more likely to both be in an age range where reciprocal IVF is straightforward and attractive.⁷ When studies adjust for the egg provider’s age, the gap between reciprocal and standard IVF essentially vanishes, which is strong evidence that the method itself is not what drives differences in outcome. Age is.

This creates a practical decision point for couples where there is a meaningful age gap. If one partner is 30 and the other is 38, having the younger partner provide the eggs and the older partner carry the pregnancy gives you the best of both worlds: younger eggs and a uterus that is still perfectly capable. Some clinics recommend exactly this arrangement, though each couple’s medical circumstances are different and fertility testing of both partners should guide the choice.

Pregnancy Risks Specific to Carrying a Partner’s Embryo

Here is where reciprocal IVF departs from standard IVF in ways that go beyond success rates. Carrying an embryo made from another person’s egg is immunologically different from carrying your own. The gestational carrier’s immune system encounters genetic material that is entirely foreign on the egg side, similar to what happens in traditional donor-egg IVF. Research on assisted reproduction broadly has linked donor-oocyte pregnancies to a higher risk of preeclampsia, with potential mechanisms including the immune response to allogenic (non-self) genetic material and differences in how the placenta implants.⁸

The data specific to reciprocal IVF is still limited and somewhat mixed. One systematic review found comparable rates of hypertensive disease in pregnancy between reciprocal IVF and intrauterine insemination.⁹ But a different study captured in a meta-analysis reported higher rates of hypertensive disorders in co-IVF pregnancies, around 24 percent compared to about 13 percent in control groups, along with higher gestational diabetes rates of roughly 10 percent versus under 2 percent.¹⁰ The same meta-analysis also noted lower birthweights in reciprocal IVF pregnancies.

The honest assessment is that the evidence here is thin. Most reciprocal IVF studies have focused on pregnancy and live birth rates rather than detailed obstetric outcomes, and sample sizes for complication tracking remain small. A SWOT analysis of the reciprocal IVF literature flagged increased pregnancy complications and insufficient safety data as key threats that need more research.¹¹ If you are considering reciprocal IVF, it is worth discussing these potential risks with your fertility specialist, particularly if you have preexisting risk factors for hypertension or diabetes. The risk profile is probably similar to standard donor-egg IVF, but no one has yet run large enough studies to say that with confidence.

What Reciprocal IVF Actually Involves Step by Step

Understanding the logistics helps explain both the costs and some of the clinical considerations that feed into success rates. In a reciprocal IVF cycle, both partners undergo medical treatment, which doubles several parts of the process compared with standard IVF where only one partner is involved.

The egg provider goes through ovarian stimulation with injectable hormones for roughly ten to fourteen days, followed by an egg retrieval procedure. Those eggs are fertilized in the lab with donor sperm, and the resulting embryos are cultured. Meanwhile, the receiving partner takes hormones, typically estrogen and progesterone, to prepare her uterine lining for embryo transfer. The timing of both protocols has to be coordinated, though many clinics now freeze all embryos and do a frozen embryo transfer in a separate cycle, which reduces the scheduling pressure.

Fresh versus frozen transfer is a relevant detail for success rates. Most of the large studies cited above include both fresh and frozen transfers in their outcome data. The shift toward freeze-all protocols in IVF generally has been associated with slightly higher per-transfer success in some populations, partly because it allows better uterine preparation without the hormonal disruption caused by simultaneous ovarian stimulation. For reciprocal IVF specifically, freeze-all is especially natural since the two partners are on different hormonal timelines anyway.

Cost is a practical consideration that the clinical literature does not address directly but that affects most couples’ decisions. Because two partners require medical treatment and monitoring, reciprocal IVF typically costs more than standard IVF or intrauterine insemination. The additional expense includes the stimulation medications for the egg provider, the monitoring ultrasounds and bloodwork for both partners, and the lab fees for fertilization and embryo culture. Insurance coverage varies widely, and in many places reciprocal IVF is not classified the same way as medically necessary IVF for infertility, which can limit reimbursement.

Legal and Regulatory Hurdles

Reciprocal IVF sits in a regulatory gray area in several countries. The procedure does not fit neatly into the standard donor-egg framework because the egg provider is not an anonymous or known third-party donor but rather one of the intended parents. In Sweden, for example, fertility practitioners have reported that partner egg donation through ROPA challenges established clinical reasoning about donor and recipient assessment, creating confusion in how the process is regulated.¹²

Some countries do not offer reciprocal IVF at all, either because same-sex assisted reproduction is legally restricted or because the regulatory framework categorizes the procedure as egg donation and imposes the same screening and consent requirements applied to unrelated donors. In places where it is available, the legal parentage question can be complicated. In many U.S. states, the partner who carries and delivers the baby is presumed to be the legal parent, while the genetic parent may need to complete an adoption or obtain a court order to be recognized. This varies enormously by jurisdiction and is worth investigating with a family law attorney before starting treatment.

These barriers do not affect clinical success rates, but they affect access, and reduced access means fewer couples going through the procedure, which in turn means smaller studies and less robust data on outcomes. It is a cycle that researchers have flagged as a limitation of the field.

When a Transgender Partner Provides the Eggs

Reciprocal IVF is not limited to cisgender lesbian couples. Transgender men and nonbinary people with ovaries can serve as the egg provider in a reciprocal arrangement with a partner who carries the pregnancy. The key clinical question is whether prior or ongoing testosterone therapy affects egg quality and, by extension, IVF outcomes.

The largest study to date on IVF outcomes in transgender men found that egg retrieval produced an average of about 20 oocytes per cycle, slightly higher than the average of about 16 in cisgender patients. The total gonadotropin dose needed was higher in the transgender group, suggesting the ovaries required more stimulation, but all seven couples who proceeded to embryo transfer achieved live births.¹³ Those results are reassuring, though the number of transfers was small.

A case report added nuance by describing a successful pregnancy using eggs from a transgender man who had been maintained on testosterone. The treating team noted that testosterone might increase the rate of chromosomally abnormal eggs, drawing a parallel with research in cisgender women with polycystic ovary syndrome where elevated testosterone has been studied in relation to miscarriage risk. However, other research in that population found no impact on miscarriage, and the overall evidence remains unsettled. The case also observed that the transgender patient had an above-average ovarian reserve, which the authors attributed to the androgenic hormone environment, and required a longer-than-typical stimulation course of 14 days.¹⁴

For transgender individuals considering this path, the practical takeaway is that IVF outcomes can be excellent even after testosterone therapy, but the stimulation protocol may need to be adjusted, costs could be somewhat higher due to longer stimulation and higher medication doses, and preimplantation genetic testing of embryos may be worth discussing with your clinic. The field is moving quickly, and larger studies are underway, but the early data is more encouraging than many patients and providers initially expected.

Choosing Who Provides the Eggs and Who Carries

One of the unique features of reciprocal IVF is that the couple gets to decide which partner takes which role, and that decision has real implications for success. Fertility clinics typically evaluate both partners before recommending a configuration. The evaluation looks at ovarian reserve (how many eggs each partner is likely to produce), uterine anatomy, any medical history that would affect pregnancy, and each partner’s age.

In most cases, the younger partner or the one with the higher ovarian reserve provides the eggs, while the partner with the more favorable uterine environment carries. Sometimes couples want to reverse these roles for personal or emotional reasons, and that is an entirely valid choice, but the success rates will reflect the biology of whoever ends up in each role. A couple where a 36-year-old provides the eggs will have different odds than one where a 28-year-old does, regardless of which partner carries.

Some couples pursue multiple rounds with the roles reversed between children, so each partner gets to experience both the genetic and gestational connection. The clinical data on role reversal between siblings is sparse, but the Brazilian clinic study found that about a fifth of the couples in their sample eventually underwent treatment where roles switched for a subsequent child.¹⁵ Success in the second configuration depends on the same factors as the first: the egg provider’s age and ovarian reserve at the time of retrieval, and the carrier’s uterine health.

For couples where one partner has a medical reason not to undergo ovarian stimulation, such as a contraindication to the hormonal medications, a history of ovarian surgery, or premature ovarian insufficiency, the choice is made for them. Reciprocal IVF still works beautifully in these situations as long as the other partner has adequate ovarian function and the first partner can safely carry a pregnancy. The flexibility of separating the genetic and gestational roles is one of the procedure’s core strengths, and it explains why cumulative success rates often exceed those of standard IVF, where everything depends on one person’s body doing both jobs well.